Claire Reiss, a major owner of Biocept, recently acquired 614,273 shares of the company. The buys took place at $1.00 per share, on May 04, 2016. Reiss now owns 2,472,028 shares of the company. Reiss operates out of San Diego, CA. Some additional info was provided as follows:
Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase .70 shares of Common Stock for $1.00 per unit.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
Departure of Directors or Certain - Sept. 8, 2017
Biocept Just Received a Notice of Effectiveness - Aug. 30, 2017
Biocept just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 30, 2017